BioSpace News Archive

Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, announces the opening of its new headquarters and its research facilities in Gaithersburg, Maryland.

On January 8, 2018, the ContraVir Executive Team met with the FDA’s Division of Antiviral Products at the Center for Drug Evaluation and Research, to review and discuss the data generated for TXL.

GTG will provide a market update as soon as it is able to conclude that review by the ASX.

The company has strengthened its core team with two experienced drug development professionals.

Ms. Turner will oversee all legal matters for the Company and will report to Sangamo’s chief executive officer.

Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss the company’s results in greater detail.

Human CAR+ T cells with membrane-bound IL-15 manufactured in less than two days exhibited anti-tumor activity and persistence in pre-clinical studies.

This alliance will see Proteomics International applying its Promarker discovery platform to formulate a new series of predictive diagnostics and analytical services capabilities in compliment to CPR’s position as an APAC-based leader in the provision of clinical services and laboratory testing in clinical trials.

The new data, sourced by MTPConnect from the ABS, highlights the progress the local MTP sector has made to maintain and extend its world-class standing in recent years.

The company issued the statement in response to a motion filed by the Office of the Maryland Attorney General: